imiquimod has been researched along with sesquiterpenes in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Chen, HX; Dong, CZ; Du, ZY; Fang, YX; Li, PH; Li, YL; Liu, GR; Tang, YD; Yan, L; Zhang, K; Zhou, W | 1 |
Hiebert, P; Kim, TG; Kim, YS; Lee, J; Song, K; Werner, S | 1 |
Lian, LH; Nan, JX; Wu, YL; Yang, HX; Zhan, ZY; Zhang, ZH | 1 |
3 other study(ies) available for imiquimod and sesquiterpenes
Article | Year |
---|---|
Aromatic-turmerone ameliorates imiquimod-induced psoriasis-like inflammation of BALB/c mice.
Topics: Animals; Anti-Inflammatory Agents; CD8-Positive T-Lymphocytes; Cyclooxygenase 2; Cytokines; Female; Imiquimod; Ketones; Mice; Mice, Inbred BALB C; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Psoriasis; Sesquiterpenes | 2018 |
Tussilagonone Ameliorates Psoriatic Features in Keratinocytes and Imiquimod-Induced Psoriasis-Like Lesions in Mice via NRF2 Activation.
Topics: Administration, Cutaneous; Adult; Animals; Anti-Inflammatory Agents; Cell Line; Cell Proliferation; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Imiquimod; Keratinocytes; Mice; NF-E2-Related Factor 2; Pentanoic Acids; Psoriasis; Sesquiterpenes; Tussilago | 2020 |
Potential skin health promoting benefits of costunolide: a therapeutic strategy to improve skin inflammation in imiquimod-induced psoriasis.
Topics: Animals; Cytokines; Dermatitis; Disease Models, Animal; Health Promotion; Imiquimod; Inflammation; Mice; Mice, Inbred BALB C; Psoriasis; Sesquiterpenes; Skin | 2023 |